DE69019190T2 - Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung. - Google Patents

Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.

Info

Publication number
DE69019190T2
DE69019190T2 DE69019190T DE69019190T DE69019190T2 DE 69019190 T2 DE69019190 T2 DE 69019190T2 DE 69019190 T DE69019190 T DE 69019190T DE 69019190 T DE69019190 T DE 69019190T DE 69019190 T2 DE69019190 T2 DE 69019190T2
Authority
DE
Germany
Prior art keywords
iddm
islamic
ica
molecular cloning
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69019190T
Other languages
English (en)
Other versions
DE69019190D1 (de
Inventor
Daniel Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of DE69019190D1 publication Critical patent/DE69019190D1/de
Publication of DE69019190T2 publication Critical patent/DE69019190T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE69019190T 1989-02-17 1990-02-03 Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung. Expired - Lifetime DE69019190T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (2)

Publication Number Publication Date
DE69019190D1 DE69019190D1 (de) 1995-06-14
DE69019190T2 true DE69019190T2 (de) 1995-09-14

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019190T Expired - Lifetime DE69019190T2 (de) 1989-02-17 1990-02-03 Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.

Country Status (14)

Country Link
EP (1) EP0383129B1 (de)
JP (1) JP2858467B2 (de)
AT (1) ATE122394T1 (de)
AU (1) AU626636B2 (de)
CA (1) CA2010275C (de)
DE (1) DE69019190T2 (de)
DK (1) DK0383129T3 (de)
ES (1) ES2072928T3 (de)
FI (1) FI103730B1 (de)
GR (1) GR3017019T3 (de)
IE (1) IE66997B1 (de)
IL (1) IL93397A (de)
NO (1) NO306996B1 (de)
PT (1) PT93166B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規reg蛋白質
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
ATE268908T1 (de) 1990-09-07 2004-06-15 Univ California Verfahren zur diagnose und behandlung von diabetes
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
AU8864791A (en) * 1990-10-02 1992-04-28 Trigen Incorporated Antibodies and methods for diagnosis and treatment of diabetes
CA2103159A1 (en) * 1991-05-15 1992-11-16 Ake Lernmark Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
EP0627934A4 (de) * 1992-02-27 1997-01-08 Univ Leland Stanford Junior Frühes antigen für autoimmun-diabete.
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
JP2001527403A (ja) * 1997-04-25 2001-12-25 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE53862T1 (de) * 1982-01-22 1990-06-15 Cetus Corp Verfahren zur charakterisierung von hla und die darin benutzten cdns-testmittel.
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
EP0229782B1 (de) * 1985-06-14 1992-11-04 Bristol-Myers Squibb Company Verfahren zur identifizierung von mit gesteigerter diabetesgefahr assoziierten allelen
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
WO1988010120A1 (en) * 1987-06-24 1988-12-29 Brigham And Women's Hospital Treatment of autoimmune diseases by oral administration of autoantigens

Also Published As

Publication number Publication date
PT93166A (pt) 1990-08-31
PT93166B (pt) 1997-11-28
AU626636B2 (en) 1992-08-06
CA2010275A1 (en) 1990-08-17
FI900759A0 (fi) 1990-02-15
ES2072928T3 (es) 1995-08-01
EP0383129B1 (de) 1995-05-10
IE66997B1 (en) 1996-02-21
CA2010275C (en) 2000-08-29
FI103730B (fi) 1999-08-31
JP2858467B2 (ja) 1999-02-17
EP0383129A3 (de) 1991-07-31
IL93397A (en) 1997-06-10
NO900474L (no) 1990-08-20
NO306996B1 (no) 2000-01-24
JPH0347133A (ja) 1991-02-28
EP0383129A2 (de) 1990-08-22
FI103730B1 (fi) 1999-08-31
NO900474D0 (no) 1990-02-01
ATE122394T1 (de) 1995-05-15
GR3017019T3 (en) 1995-11-30
DK0383129T3 (da) 1995-10-09
IE900589L (en) 1990-08-17
DE69019190D1 (de) 1995-06-14
AU4988390A (en) 1990-08-23
IL93397A0 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
DE69019190D1 (de) Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
NO975435D0 (no) Modifiserte/chimeriske proteiner samt anvendelser derav
ATE53219T1 (de) Htlv iii polypeptide.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
DE59010915D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
ATE132197T1 (de) Monoklonale antikörper
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
EP0869177A3 (de) Menschliche Typ-A und Typ-B Blutplättchen abstammenden Wachstumfaktor Rezeptoren
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
EP0293827A3 (de) Probe für Leishmaniosis
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US